QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)
QQQ   432.79 (+0.19%)
AAPL   188.32 (-0.58%)
MSFT   414.11 (+0.01%)
META   470.00 (+0.09%)
GOOGL   145.91 (+0.25%)
AMZN   169.84 (-0.40%)
TSLA   189.56 (+1.06%)
NVDA   696.41 (-0.65%)
NIO   5.82 (-0.68%)
AMD   169.35 (-0.93%)
BABA   70.74 (-3.94%)
T   16.82 (-2.94%)
F   12.83 (+0.23%)
MU   84.88 (-0.34%)
CGC   4.11 (-4.86%)
GE   139.07 (+0.41%)
DIS   110.54 (+11.50%)
AMC   4.09 (+3.81%)
PFE   27.56 (+0.00%)
PYPL   56.13 (-11.24%)
XOM   103.97 (+1.71%)

Colgate-Palmolive (CL) Stock Price, News & Analysis

$84.26
+0.39 (+0.47%)
(As of 02/8/2024 ET)
Today's Range
$83.50
$84.30
50-Day Range
$76.28
$86.12
52-Week Range
$67.62
$86.14
Volume
4.82 million shs
Average Volume
5.57 million shs
Market Capitalization
$69.37 billion
P/E Ratio
30.31
Dividend Yield
2.28%
Price Target
$86.93

Colgate-Palmolive MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.77 Rating Score
Upside/​Downside
3.2% Upside
$86.93 Price Target
Short Interest
Healthy
1.18% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.16
Upright™ Environmental Score
News Sentiment
0.58mentions of Colgate-Palmolive in the last 14 days
Based on 18 Articles This Week
Insider Trading
Selling Shares
$7.64 M Sold Last Quarter
Proj. Earnings Growth
8.33%
From $3.48 to $3.77 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.78 out of 5 stars

Consumer Staples Sector

11th out of 134 stocks

Toilet Preparations Industry

1st out of 12 stocks


CL stock logo

About Colgate-Palmolive Stock (NYSE:CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

CL Stock Price History

CL Stock News Headlines

Yes, Colgate-Palmolive can clean its way to a fresh all-time high
Colgate-Palmolive is in an upswing driven by analysts' sentiment and results; it may experience a price-multiple expansion and hit new highs this year
3 high-yielding Dividend Kings: Buy, sell or hold? (CL)
These Dividend Kings have higher-than-average yields relative to the broad market and catalysts to drive their shares higher over the long term.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Three defensive stocks to hedge your risks this year (CL)
Now that the market is showing signs of a potential slowdown, it could be time for you to align your portfolio with some defensive names.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Colgate-Palmolive (NYSE:CL) EVP Gregory Malcolm Sells 8,930 Shares
Colgate-Palmolive (NYSE:CL) PT Raised to $93.00 at Morgan Stanley
Hershey, Colgate-Palmolive, Flywire: Trending tickers
See More Headlines
Receive CL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 11/15 Dividend
10/20/2023
Dividend Payable
11/15/2023
Ex-Dividend for 2/15 Dividend
1/19/2024
Last Earnings
1/26/2024
Today
2/08/2024
Dividend Payable
2/15/2024
Next Earnings (Estimated)
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Toilet preparations
Sub-Industry
Household Products
CUSIP
19416210
Employees
33,800
Year Founded
1806

Price Target and Rating

Average Stock Price Target
$86.93
High Stock Price Target
$95.00
Low Stock Price Target
$76.00
Potential Upside/Downside
+3.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.77
Research Coverage
13 Analysts

Profitability

Net Income
$2.30 billion
Pretax Margin
17.43%

Debt

Sales & Book Value

Annual Sales
$19.46 billion
Cash Flow
$3.95 per share
Book Value
$1.16 per share

Miscellaneous

Free Float
820,573,000
Market Cap
$69.06 billion
Optionable
Optionable
Beta
0.42

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Colgate-Palmolive was last updated on Monday, January 29, 2024 at 1:41 PM.

Pros

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

  • Strong brand presence: Colgate-Palmolive is a well-established company with a strong brand presence in the consumer staples sector. This can provide stability and potential for long-term growth.
  • Global market reach: Colgate-Palmolive operates in multiple countries around the world, allowing investors to benefit from its global market reach and potential for international expansion.
  • Consistent dividend payments: Colgate-Palmolive has a history of consistently paying dividends to its shareholders. This can provide investors with a steady income stream.
  • Innovation and product development: Colgate-Palmolive invests in innovation and product development to stay competitive in the market. This can lead to the introduction of new and improved products, attracting consumers and driving sales.
  • Positive financial performance: Colgate-Palmolive has shown positive financial performance in recent periods, with increasing revenues and profitability. This indicates the company's ability to generate returns for investors.

Cons

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

  • Competition in the consumer staples sector: The consumer staples sector is highly competitive, with many companies vying for market share. Colgate-Palmolive faces competition from both established players and emerging brands, which could impact its market position and profitability.
  • Regulatory challenges: The consumer staples industry is subject to various regulations, including those related to product safety, labeling, and advertising. Compliance with these regulations can be costly and may affect Colgate-Palmolive's operations and financial performance.
  • Currency exchange risks: Colgate-Palmolive operates in multiple countries, which exposes it to currency exchange risks. Fluctuations in exchange rates can impact the company's revenues and profitability, especially in markets with volatile currencies.
  • Changing consumer preferences: Consumer preferences and trends can change over time, affecting the demand for Colgate-Palmolive's products. The company needs to continuously adapt to evolving consumer needs and preferences to maintain its market position.
  • Impact of economic downturns: The consumer staples sector is not immune to economic downturns. During periods of economic recession or slowdown, consumer spending on non-essential products may decrease, which could impact Colgate-Palmolive's sales and profitability.














CL Stock Analysis - Frequently Asked Questions

Should I buy or sell Colgate-Palmolive stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.
View CL analyst ratings
or view top-rated stocks.

What is Colgate-Palmolive's stock price target for 2024?

13 analysts have issued 12 month price objectives for Colgate-Palmolive's stock. Their CL share price targets range from $76.00 to $95.00. On average, they expect the company's share price to reach $86.93 in the next year. This suggests a possible upside of 3.2% from the stock's current price.
View analysts price targets for CL
or view top-rated stocks among Wall Street analysts.

How have CL shares performed in 2024?

Colgate-Palmolive's stock was trading at $79.71 at the beginning of 2024. Since then, CL stock has increased by 5.7% and is now trading at $84.26.
View the best growth stocks for 2024 here
.

Are investors shorting Colgate-Palmolive?

Colgate-Palmolive saw a drop in short interest during the month of December. As of December 31st, there was short interest totaling 9,840,000 shares, a drop of 9.5% from the December 15th total of 10,870,000 shares. Based on an average daily volume of 4,720,000 shares, the days-to-cover ratio is currently 2.1 days. Currently, 1.2% of the shares of the stock are sold short.
View Colgate-Palmolive's Short Interest
.

When is Colgate-Palmolive's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 26th 2024.
View our CL earnings forecast
.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) posted its quarterly earnings results on Friday, January, 26th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.02. The firm had revenue of $4.95 billion for the quarter, compared to analysts' expectations of $4.89 billion. Colgate-Palmolive had a trailing twelve-month return on equity of 509.75% and a net margin of 11.82%. The business's revenue was up 6.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.77 earnings per share.
Read the conference call transcript
.

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive declared a quarterly dividend on Thursday, January 11th. Stockholders of record on Monday, January 22nd will be paid a dividend of $0.48 per share on Thursday, February 15th. This represents a $1.92 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend is Friday, January 19th.
Read our dividend analysis for CL
.

Is Colgate-Palmolive a good dividend stock?

Colgate-Palmolive (NYSE:CL) pays an annual dividend of $1.92 per share and currently has a dividend yield of 2.29%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 69.06%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CL will have a dividend payout ratio of 50.93% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CL.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive announced that its board has approved a stock repurchase plan on Thursday, March 10th 2022, which allows the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 8.1% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its stock is undervalued.

What guidance has Colgate-Palmolive issued on next quarter's earnings?

Colgate-Palmolive issued an update on its FY 2024 earnings guidance on Friday, January, 26th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19.7 billion-$20.2 billion, compared to the consensus revenue estimate of $20.1 billion.

What is Noel Wallace's approval rating as Colgate-Palmolive's CEO?

195 employees have rated Colgate-Palmolive Chief Executive Officer Noel Wallace on Glassdoor.com. Noel Wallace has an approval rating of 95% among the company's employees. This puts Noel Wallace in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), Coca-Cola (KO), Intel (INTC), McDonald's (MCD) and Walt Disney (DIS).

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by many different institutional and retail investors. Top institutional shareholders include First Eagle Investment Management LLC (1.33%), GUARDCAP ASSET MANAGEMENT Ltd (0.81%), Massachusetts Financial Services Co. MA (0.76%), Nordea Investment Management AB (0.66%), California Public Employees Retirement System (0.60%) and Charles Schwab Investment Management Inc. (0.54%). Insiders that own company stock include C Martin Harris, Gregory Malcolm, Jennifer Daniels, John P Bilbrey, John T Cahill, John W Kooyman, Lorrie M Norrington, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Sally Massey and Stephen I Sadove.
View institutional ownership trends
.

How do I buy shares of Colgate-Palmolive?

Shares of CL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Colgate-Palmolive have any subsidiaries?
The following companies are subsidiares of Colgate-Palmolive: 887357 Ontario Inc., COLGALIVE S.A., CP GABA GmbH, CP International Holding C.V., CP West East Investment Limited, Cleaning Dimensions Inc., Colgate (BVI) Limited, Colgate (Guangzhou) Company Limited, Colgate (U.K.) Limited, Colgate Business Services of the Americas S.C., Colgate Flavors and Fragrances Inc., Colgate Global Business Services Private Limited, Colgate Holdings, Colgate Inc., Colgate Oral Pharmaceuticals Inc., Colgate Palmolive Ghana Limited, Colgate Palmolive Holding S.Com.P.A., Colgate Palmolive Nouvelle Caledonie Sarl, Colgate Palmolive Tanzania Limited, Colgate Sanxiao Company Limited, Colgate Venture Company Inc., Colgate-Palmolive (America) Inc., Colgate-Palmolive (Asia) Pte Ltd, Colgate-Palmolive (Blantyre) Limited, Colgate-Palmolive (Brunei) Sdn Bhn, Colgate-Palmolive (Central America) Inc., Colgate-Palmolive (Central America) Inc. y Compañia Limitada, Colgate-Palmolive (Centro America) S.A., Colgate-Palmolive (China) Co. Ltd, Colgate-Palmolive (Costa Rica) S.A., Colgate-Palmolive (Dominica) Inc., Colgate-Palmolive (Dominican Republic) Inc., Colgate-Palmolive (East Africa) Limited, Colgate-Palmolive (Eastern) Pte. Ltd., Colgate-Palmolive (Egypt) S.A.E., Colgate-Palmolive (Far East) Sdn Bhd, Colgate-Palmolive (Fiji) Pte Limited, Colgate-Palmolive (Gabon) S.A., Colgate-Palmolive (Guyana) Ltd., Colgate-Palmolive (H.K.) Limited, Colgate-Palmolive (Hellas) S.A. I.C., Colgate-Palmolive (Hong Kong) Holding Limited, Colgate-Palmolive (Kazakhstan) L.L.P., Colgate-Palmolive (Latvia) Ltd., Colgate-Palmolive (Malaysia) Sdn Bhd, Colgate-Palmolive (Middle East Exports) Ltd., Colgate-Palmolive (Myanmar) Limited, Colgate-Palmolive (New York) Inc., Colgate-Palmolive (Poland) Sp. z o.o., Colgate-Palmolive (Proprietary) Limited, Colgate-Palmolive (Research & Development) Inc., Colgate-Palmolive (Romania) SRL, Colgate-Palmolive (Thailand) Limited, Colgate-Palmolive (UK) Limited, Colgate-Palmolive (Uganda) Limited, Colgate-Palmolive (Vietnam) Ltd., Colgate-Palmolive (Zambia) Inc., Colgate-Palmolive (Zimbabwe) Inc., Colgate-Palmolive A.B., Colgate-Palmolive A/S, Colgate-Palmolive Adria Ltd., Colgate-Palmolive Argentina S.A., Colgate-Palmolive Asia Pacific Limited, Colgate-Palmolive Asia Pacific Treasury Services Limited, Colgate-Palmolive Belgium S.A., Colgate-Palmolive Bolivia Ltda., Colgate-Palmolive Canada Inc., Colgate-Palmolive Caricom Service Co. Inc., Colgate-Palmolive Central European Management Inc., Colgate-Palmolive Chile S.A., Colgate-Palmolive Cia., Colgate-Palmolive Comercial Ltda., Colgate-Palmolive Commercial (Hellas) SP LLC, Colgate-Palmolive Commerciale S.A.S., Colgate-Palmolive Commericale S.r.l., Colgate-Palmolive Compania Anonima, Colgate-Palmolive Company Distr. LLC, Colgate-Palmolive Company GmbH, Colgate-Palmolive Cote d’Ivoire S.A., Colgate-Palmolive Cyprus Limited, Colgate-Palmolive Development Corp., Colgate-Palmolive East West Africa Region (Pty) Ltd, Colgate-Palmolive Enterprises Inc., Colgate-Palmolive Espana S.A., Colgate-Palmolive Europe (Holdings) Sarl, Colgate-Palmolive Europe Sarl, Colgate-Palmolive Finance (UK) plc, Colgate-Palmolive Global Trading Company, Colgate-Palmolive Holding Argentina S.A., Colgate-Palmolive Holding Inc., Colgate-Palmolive Hungary Kft Limited Liability Company, Colgate-Palmolive IHQ Services (Thailand) Limited, Colgate-Palmolive Inc., Colgate-Palmolive Inc. S.A., Colgate-Palmolive Industrial Ltda., Colgate-Palmolive Industriel S.A.S., Colgate-Palmolive International Holding LLC, Colgate-Palmolive International LLC, Colgate-Palmolive Investment Co. Inc., Colgate-Palmolive Investments (BVI) Ltd., Colgate-Palmolive Investments (PNG) Ltd., Colgate-Palmolive Investments (UK) Limited, Colgate-Palmolive Investments Inc., Colgate-Palmolive Israel Ltd., Colgate-Palmolive Italia S.r.l., Colgate-Palmolive JSC, Colgate-Palmolive Lanka (Private) Limited, Colgate-Palmolive Latin America Inc., Colgate-Palmolive Limited, Colgate-Palmolive Manufacturing (Poland) Sp. z o.o., Colgate-Palmolive Marketing Sdn Bhd, Colgate-Palmolive Maroc S.A., Colgate-Palmolive Mocambique Limitada, Colgate-Palmolive NJ Inc., Colgate-Palmolive Nederland B.V., Colgate-Palmolive Norge A/S, Colgate-Palmolive Participacoes e Investimentos Imobiliarios Lda., Colgate-Palmolive Peru S.A., Colgate-Palmolive Philippines Inc., Colgate-Palmolive Pty Ltd, Colgate-Palmolive Retirement Trustee Limited, Colgate-Palmolive S.A. de C.V., Colgate-Palmolive S.p.A., Colgate-Palmolive Senegal S.A., Colgate-Palmolive Services (Hellas) LLC, Colgate-Palmolive Services (Poland) Sp. z o.o., Colgate-Palmolive Services CEW GmbH, Colgate-Palmolive Services S.A., Colgate-Palmolive Slovensko s.r.o., Colgate-Palmolive Support Services, Colgate-Palmolive Temizlik Urunleri Sanayi ve Ticart S.A., Colgate-Palmolive Transnational Inc., Colgate-Palmolive Ukraine LLC, Colgate-Palmolive Unipessoal Lda, Colgate-Palmolive de Paraguay Sociedad Anonima, Colgate-Palmolive de Puerto Rico Inc., Colgate-Palmolive del Ecuador S.A.I.C., Colgate-Palmolive del Peru (Delaware) Inc., Colgate-Palmolive Èeská republika spol. s r.o., Colpal CBS S de R. L. de C. V., Consumer Viewpoint Center Inc., Cotelle S.A., Dimac Development Corp., Dominica Coconut Products Limited, EKIB Inc., ELM Company Limited, Elta MD Holdings Inc., Elta MD Inc., EltaMD, Filorga Americas Inc., Filorga Asia Limited, Filorga Benelux SA, Filorga Cosmetiques Polska, Filorga Middle East DMCC, Filorga Portugal Unipessoal Lda., Filorga RU Limited Liability Company, GABA Europe Holding GmbH, GABA International, GABA International Holding LLC, GABA Schweiz AG, GABA Therwil GmbH, Gamma Development Co. Ltd., Global Trading and Supply LLC, Hamol Ltd., Hello Products, Hello Products LLC, Hill’s Funding Company, Hill’s Pet Nutrition (NZ) Limited, Hill’s Pet Nutrition (Thailand) Co. Ltd., Hill’s Pet Nutrition Asia Limited, Hill’s Pet Nutrition B.V., Hill’s Pet Nutrition Canada Inc., Hill’s Pet Nutrition Denmark ApS, Hill’s Pet Nutrition Espana S.L., Hill’s Pet Nutrition GmbH, Hill’s Pet Nutrition Holding B.V., Hill’s Pet Nutrition Inc., Hill’s Pet Nutrition Indiana Inc., Hill’s Pet Nutrition Italia S.r.l., Hill’s Pet Nutrition Korea Ltd., Hill’s Pet Nutrition Ltd., Hill’s Pet Nutrition Manufacturing B.V., Hill’s Pet Nutrition Manufacturing s.r.o, Hill’s Pet Nutrition Norway AS, Hill’s Pet Nutrition OOO, Hill’s Pet Nutrition Pty. Limited, Hill’s Pet Nutrition S.p.A., Hill’s Pet Nutrition SNC, Hill’s Pet Nutrition Sales Inc., Hill’s Pet Nutrition South Africa Proprietary Limited, Hill’s Pet Nutrition Sweden AB, Hill’s Pet Nutrition Switzerland GmbH, Hill’s Pet Nutrition Taiwan Ltd, Hill’s Pet Nutrition Trading (GZ) Co. Ltd, Hill’s Pet Nutrition de Mexico S.A. de C.V., Hill’s Pet Nutrition de Puerto Rico Inc., Hill’s Pet Nutrition s.r.o., Hill’s Pet Products (Benelux) S.A., Hill’s Pet Products Inc., Hill’s Veterinary Companies of America Inc., Hill’s-Colgate (Japan) Ltd., Hopro Liquidating Corp., Hygiene Systemes et Services SA, IES Enterprises Inc., Inmobiliaria Colpal S. de R.L. de C.V., Inmobiliaria Hills S.A. de C.V., Innovacion Creativa S.A. de C.V., Kolynos Corporation, Laboratoires Filorga Cosmetiques Espana S.L.U., Laboratoires Filorga Cosmetiques Italia S.R.L., Laboratoires Filorga Cosmétiques S.A., Laser Brand Toothpaste, Lournay Sales Inc., Mennen Company, Mennen Interamerica Ltd., Mennen Limited, Mennen South Africa Ltd., Mennen de Chile Ltd., Mennen de Nicargua S.A., Mission Hills Property Corporation, Mission Hills S.A. de C.V., Norwood International Incorporated, Olive Music Publishing Corporation, PCA SKIN, Paramount Research Inc., Penny LLC, Pet Chemicals Inc., Physicians Care Alliance LLC, Productos Halogenados Copalven C.A., Purity Holding Company, Purity Music Publishing Corporation, Refresh Company Limited, Samuel Taylor Holdings B.V., Sanex, Sanxiao Company Limited, Services Development Co. Ltd., Societe Generale de Negoce et de Services (GENESE) S.A., The GDN - The Global Distributive Network SAS, The Lournay Company Inc., The MPDP - The Medical and Pharmaceutic Distributive Platform SAS, The Murphy-Phoenix Company, Tom's of Maine, Tom’s of Maine Holdings Inc., Tom’s of Maine Inc., Veterinary Companies of America Inc., Vipont Pharmaceutical Inc., and XEB Inc..
Read More
This page (NYSE:CL) was last updated on 2/8/2024 by MarketBeat.com Staff

My Account -